Thought Leadership - Spherix Global Insights

Invest in intelligence that delivers

Spherix Thought Leadership

From conference presentations to white papers and other publicly shared research, access a comprehensive collection to stay informed and drive impactful decisions.

Rheumatology

Navigating the Evolving SLE/Lupus Nephritis Landscape: Keys to Successful Product Launches

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

New treatment dynamics in PNH – a chart review of 211 US PNH patients and how physicians are adapting to new treatment options

Cross Specialty

Discussion on the Inflation Reduction Act During the Healthcare Businesswomen's Association Virtual Event

Dermatology

Earlier Diagnosis and Treatment: The Key to Better Outcomes in Hidradenitis Suppurativa

Dermatology

Understand the remaining unmet need in plaque psoriasis and to uncover early perceptions of the oral small molecules in development for plaque psoriasis.

Nephrology

A Complement and B-Cell Modifying Pipeline to Address Unmet Needs in IgA Nephropathy (IgAN)

Nephrology

A Comparative View of Early Career and Established Nephrologist Perspectives

Rheumatology

Chart Audit of Over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations

Dermatology

Uptake of Secukinumab in Hidradenitis Suppurativa

Neurology

A KOL Perspective: Exclusive Interview with Dr. Naismith

Rheumatology

Not Yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance

Nephrology

Evolution of Treatment Paradigms in Diabetic Kidney Disease

Neurology

Characterization of Early Adopters of SC FcRn Blockers for gMG

Nephrology

The Untapped Potential of the ADPKD Treatment Landscape

Rheumatology

Amplifying the Lupus Patient Voice: Insights into the Diagnostic Journey and Informational Needs

Nephrology

The Meteoric Rise of SGLT2 Inhibitors in Glomerular Diseases

Dermatology

Acceptable Clinical Trial Differences vs Placebo in Plaque Psoriasis

Nephrology

A Comparative View of IgA Nephropathy Care Across Four Global Regions

Nephrology

Genetic Testing in Patients with Focal Segmental Glomerulosclerosis

Rheumatology

Specialists' Comfort with Cutaneous Lupus Erythematosus Reveals Potential Gaps and a Need for Co- Management Strategies

Neurology

The Uptake of Relyvrio™ (sodium phenylbutyrate and taurursodiol) in ALS among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists

Nephrology

Uncovering the Potential of HIF-PH Inhibitors to Treat Renal Anemia

Nephrology

Shifts in SGLT2 Inhibitor Initiation in CKD Non-Dialysis Patients

Media

Priovant’s Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch

October 10, 2025

US Rheumatologists View Cell Therapy as a Potential Game Changer, with Systemic Sclerosis Emerging as the Most Compelling Indication, According to Spherix Global Insights

October 6, 2025

Physicians Signal Cautious Enthusiasm for Gene Therapy Across Hematology, But Adoption Remains Selective

October 2, 2025

As Roche/Genentech’s Obinutuzumab (Gazyva) Nears FDA Decision, Spherix Global Insights White Paper Reveals Keys to Successful Lupus Product Launches

October 2, 2025

Talk to an expert

Andy Stankus
Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Andy Stankus
Franchise Head, Rheumatology

Kari McCarthy
Franchise Head, Nephrology

Bob Shewbrooks
Franchise Head, Neurology

Bob Shewbrooks
Franchise Head, Ophthalmology

Sarah Hendry
Franchise Head, Hematology